| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD-2002-09-2853 |
| P698 | PubMed publication ID | 12531816 |
| P2093 | author name string | D Neil Granger | |
| Steven M Albelda | |||
| Douglas B Cines | |||
| Juan-Carlos Murciano | |||
| Vladimir R Muzykantov | |||
| Silvia Muro | |||
| Melpo Christofidou-Solomidou | |||
| Lauren Koniaris | |||
| David W Harshaw | |||
| P433 | issue | 10 | |
| P304 | page(s) | 3977-3984 | |
| P577 | publication date | 2003-01-16 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface | |
| P478 | volume | 101 |
| Q37132620 | Advanced drug delivery systems for antithrombotic agents. |
| Q36445798 | Biomimetic channel modeling local vascular dynamics of pro-inflammatory endothelial changes |
| Q28596891 | Biophysically inspired model for functionalized nanocarrier adhesion to cell surface: roles of protein expression and mechanical factors |
| Q39562431 | Calcium condensed LABL-TAT complexes effectively target gene delivery to ICAM-1 expressing cells. |
| Q36346851 | Challenges in design and characterization of ligand-targeted drug delivery systems |
| Q37051502 | Chitosan-Alginate Microcapsules Provide Gastric Protection and Intestinal Release of ICAM-1-Targeting Nanocarriers, Enabling GI Targeting In Vivo |
| Q36565901 | Comparative binding, endocytosis, and biodistribution of antibodies and antibody-coated carriers for targeted delivery of lysosomal enzymes to ICAM-1 versus transferrin receptor |
| Q33606794 | Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers |
| Q43210433 | Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopes |
| Q34631547 | Distinct subcellular trafficking resulting from monomeric vs multimeric targeting to endothelial ICAM-1: implications for drug delivery |
| Q37980236 | Dynamic factors controlling targeting nanocarriers to vascular endothelium |
| Q41961966 | Effect of Glycocalyx on Drug Delivery Carriers Targeted to Endothelial Cells |
| Q40923925 | Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1. |
| Q35848131 | Endothelial targeting of a recombinant construct fusing a PECAM-1 single-chain variable antibody fragment (scFv) with prourokinase facilitates prophylactic thrombolysis in the pulmonary vasculature |
| Q35930068 | Endothelial targeting of antibody-decorated polymeric filomicelles |
| Q39636269 | Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease |
| Q50077661 | Ferritin Nanocages with Biologically Orthogonal Conjugation for Vascular Targeting and Imaging. |
| Q41824469 | Flow dynamics, binding and detachment of spherical carriers targeted to ICAM-1 on endothelial cells |
| Q50147160 | Fluorescence Microscopy Imaging Calibration for Quantifying Nanocarrier Binding to Cells During Shear Flow Exposure |
| Q47276739 | How Carrier Size and Valency Modulate Receptor-Mediated Signaling: Understanding the Link between Binding and Endocytosis of ICAM-1-Targeted Carriers. |
| Q35084785 | Inherited trombophilic states and pulmonary embolism |
| Q41933986 | Intercellular adhesion molecule 1 engagement modulates sphingomyelinase and ceramide, supporting uptake of drug carriers by the vascular endothelium |
| Q38836304 | Intra- and trans-cellular delivery of enzymes by direct conjugation with non-multivalent anti-ICAM molecules |
| Q47393214 | Lung Endothelium Targeting for Pulmonary Embolism Thrombolysis |
| Q81193915 | Lysosomal enzyme delivery by ICAM-1-targeted nanocarriers bypassing glycosylation- and clathrin-dependent endocytosis |
| Q55481390 | Monocyte Response to Different Campylobacter jejuni Lysates Involves Endoplasmic Reticulum Stress and the Lysosomal⁻Mitochondrial Axis: When Cell Death Is Better Than Cell Survival. |
| Q89457019 | Monocytes mediate homing of circulating microvesicles to the pulmonary vasculature during low-grade systemic inflammation |
| Q37683644 | New biotechnological and nanomedicine strategies for treatment of lysosomal storage disorders |
| Q34690444 | Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriers |
| Q35710262 | Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosis |
| Q36445835 | Prophylactic thrombolysis by thrombin-activated latent prourokinase targeted to PECAM-1 in the pulmonary vasculature |
| Q36721811 | Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammation |
| Q89473831 | Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrier |
| Q47336012 | Site-Specific Modification of Single-Chain Antibody Fragments for Bioconjugation and Vascular Immunotargeting. |
| Q37672410 | Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders |
| Q30475849 | Targeted delivery of therapeutics to endothelium |
| Q38598987 | Targeted endothelial nanomedicine for common acute pathological conditions |
| Q35098774 | Targeted modulation of reactive oxygen species in the vascular endothelium |
| Q34935960 | Targeting antioxidant and antithrombotic biotherapeutics to endothelium |
| Q30488087 | Targeting mesenchymal stem cells to activated endothelial cells |
| Q38151092 | Targeting sites of inflammation: intercellular adhesion molecule-1 as a target for novel inflammatory therapies |
| Q47250590 | Targeting therapeutics to endothelium: are we there yet? |
| Q38749932 | The Future of Nanoparticle-Directed Venous Therapy |
| Q36644685 | Therapy for Gaucher disease: don't stop thinking about tomorrow |
| Q36507703 | Thermal facilitation of lymphocyte trafficking involves temporal induction of intravascular ICAM-1. |
| Q89584879 | Tissue Targeting and Ultrasound-Targeted Microbubble Destruction Delivery of Plasmid DNA and Transfection In Vitro |
| Q39100187 | Translational initiatives in thrombolytic therapy |
| Q36291228 | Transport of nanocarriers across gastrointestinal epithelial cells by a new transcellular route induced by targeting ICAM-1. |
| Q30355578 | Ultrasound combined with targeted cationic microbubble-mediated angiogenesis gene transfection improves ischemic heart function. |
| Q35001301 | Utilization of I-domain of LFA-1 to Target Drug and Marker Molecules to Leukocytes. |
| Q37902114 | Vascular targeting of antithrombotic agents |
| Q27026630 | Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm |
Search more.